Informed Consent At minimum, discuss: Expected weight loss (typically 10-15% body weight with GLP-1s over 6-12 months) Side effects (GI upset with GLP-1s, insomnia/tachycardia with phentermine) Off-label use if applicable (e.g., prescribing Ozempic for obesity when Wegovy is the approved versionsome states like Mississippi prohibit this) Need for lifestyle changes (medication alone wont work) Follow-up schedule Document the conversation in the chart
Allowing dose escalation to happen slowly allows tachyphylaxis to occur & allows our bodies to adjust to it
Youll leave with deep insight and understanding into which products are right for you and how youll cycle through them, while setting clear expectations to ensure you dont waste time or money
That said, I think this is an interesting approval, but I do not expect it to dramatically reshape the GLP-1 landscape, he went on
During treatment, patients have an opportunity to develop habits that support long-term weight management , including: Nutrition Habits Creating balanced meals with enough protein, fiber, and healthy fats can help control hunger naturally after treatment ends